Cinevista Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 4, 2025, 12:47 am

Competitors of Cinevista Ltd

All Competitor Stocks of Cinevista Ltd

Quarterly Result

Last Updated: August 1, 2025, 10:40 pm

Below is a detailed analysis of the quarterly data for Cinevista Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 4.63 Cr.. The value appears to be declining and may need further review. It has decreased from 11.47 Cr. (Mar 2025) to 4.63 Cr., marking a decrease of 6.84 Cr..
• For Expenses, as of Jun 2025, the value is 2.69 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 26.60 Cr. (Mar 2025) to 2.69 Cr., marking a decrease of 23.91 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.94 Cr.. The value appears strong and on an upward trend. It has increased from -15.13 Cr. (Mar 2025) to 1.94 Cr., marking an increase of 17.07 Cr..
• For OPM %, as of Jun 2025, the value is 41.90%. The value appears strong and on an upward trend. It has increased from -131.91% (Mar 2025) to 41.90%, marking an increase of 173.81%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.03 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.03 Cr..
• For Interest, as of Jun 2025, the value is 0.90 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.92 Cr. (Mar 2025) to 0.90 Cr., marking a decrease of 0.02 Cr..
• For Depreciation, as of Jun 2025, the value is 0.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.06 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.99 Cr.. The value appears strong and on an upward trend. It has increased from -16.08 Cr. (Mar 2025) to 0.99 Cr., marking an increase of 17.07 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 60.88% (Mar 2025) to 0.00%, marking a decrease of 60.88%.
• For Net Profit, as of Jun 2025, the value is 0.99 Cr.. The value appears strong and on an upward trend. It has increased from -25.87 Cr. (Mar 2025) to 0.99 Cr., marking an increase of 26.86 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.17. The value appears strong and on an upward trend. It has increased from -4.50 (Mar 2025) to 0.17, marking an increase of 4.67.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:30 am

Growth

Last Updated: September 5, 2025, 2:00 am

Balance Sheet

Last Updated: December 4, 2025, 1:07 am

Below is a detailed analysis of the balance sheet data for Cinevista Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
• For Reserves, as of Sep 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 1.00 Cr..
• For Borrowings, as of Sep 2025, the value is 23.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 25.00 Cr. (Mar 2025) to 23.00 Cr., marking a decrease of 2.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 68.00 Cr.. The value appears to be improving (decreasing). It has decreased from 70.00 Cr. (Mar 2025) to 68.00 Cr., marking a decrease of 2.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 143.00 Cr.. The value appears to be improving (decreasing). It has decreased from 146.00 Cr. (Mar 2025) to 143.00 Cr., marking a decrease of 3.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 23.00 Cr., marking an increase of 1.00 Cr..
• For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 119.00 Cr.. The value appears to be declining and may need further review. It has decreased from 121.00 Cr. (Mar 2025) to 119.00 Cr., marking a decrease of 2.00 Cr..
• For Total Assets, as of Sep 2025, the value is 143.00 Cr.. The value appears to be declining and may need further review. It has decreased from 146.00 Cr. (Mar 2025) to 143.00 Cr., marking a decrease of 3.00 Cr..

Notably, the Reserves (40.00 Cr.) exceed the Borrowings (23.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Cinevista Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -5.37. This value is below the healthy minimum of 5. It has decreased from -1.27 (Mar 24) to -5.37, marking a decrease of 4.10.
• For Diluted EPS (Rs.), as of Mar 25, the value is -5.37. This value is below the healthy minimum of 5. It has decreased from -1.27 (Mar 24) to -5.37, marking a decrease of 4.10.
• For Cash EPS (Rs.), as of Mar 25, the value is -5.34. This value is below the healthy minimum of 3. It has decreased from -1.26 (Mar 24) to -5.34, marking a decrease of 4.08.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -6.77. It has decreased from -1.99 (Mar 24) to -6.77, marking a decrease of 4.78.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 8.58. It has decreased from 13.94 (Mar 24) to 8.58, marking a decrease of 5.36.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1.96. It has increased from 0.07 (Mar 24) to 1.96, marking an increase of 1.89.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -3.04. This value is below the healthy minimum of 2. It has decreased from -0.58 (Mar 24) to -3.04, marking a decrease of 2.46.
• For PBIT / Share (Rs.), as of Mar 25, the value is -3.07. This value is below the healthy minimum of 0. It has decreased from -0.60 (Mar 24) to -3.07, marking a decrease of 2.47.
• For PBT / Share (Rs.), as of Mar 25, the value is -3.71. This value is below the healthy minimum of 0. It has decreased from -1.12 (Mar 24) to -3.71, marking a decrease of 2.59.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -5.37. This value is below the healthy minimum of 2. It has decreased from -1.27 (Mar 24) to -5.37, marking a decrease of 4.10.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -5.37. This value is below the healthy minimum of 2. It has decreased from -1.27 (Mar 24) to -5.37, marking a decrease of 4.10.
• For PBDIT Margin (%), as of Mar 25, the value is -155.16. This value is below the healthy minimum of 10. It has increased from -784.10 (Mar 24) to -155.16, marking an increase of 628.94.
• For PBIT Margin (%), as of Mar 25, the value is -156.52. This value is below the healthy minimum of 10. It has increased from -805.26 (Mar 24) to -156.52, marking an increase of 648.74.
• For PBT Margin (%), as of Mar 25, the value is -189.13. This value is below the healthy minimum of 10. It has increased from -1,494.46 (Mar 24) to -189.13, marking an increase of 1,305.33.
• For Net Profit Margin (%), as of Mar 25, the value is -273.90. This value is below the healthy minimum of 5. It has increased from -1,702.56 (Mar 24) to -273.90, marking an increase of 1,428.66.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -273.90. This value is below the healthy minimum of 8. It has increased from -1,702.56 (Mar 24) to -273.90, marking an increase of 1,428.66.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Return on Capital Employeed (%), as of Mar 25, the value is -24.05. This value is below the healthy minimum of 10. It has decreased from -3.35 (Mar 24) to -24.05, marking a decrease of 20.70.
• For Return On Assets (%), as of Mar 25, the value is -21.71. This value is below the healthy minimum of 5. It has decreased from -4.20 (Mar 24) to -21.71, marking a decrease of 17.51.
• For Long Term Debt / Equity (X), as of Mar 25, the value is -0.61. This value is below the healthy minimum of 0.2. It has increased from -2.02 (Mar 24) to -0.61, marking an increase of 1.41.
• For Total Debt / Equity (X), as of Mar 25, the value is -0.62. This value is within the healthy range. It has increased from -2.06 (Mar 24) to -0.62, marking an increase of 1.44.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.07. It has increased from 0.00 (Mar 24) to 0.07, marking an increase of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has increased from 0.28 (Mar 24) to 1.59, marking an increase of 1.31.
• For Quick Ratio (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.05.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.18, marking an increase of 0.18.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -4.76. This value is below the healthy minimum of 3. It has decreased from -1.14 (Mar 24) to -4.76, marking a decrease of 3.62.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -7.40. This value is below the healthy minimum of 3. It has decreased from -1.47 (Mar 24) to -7.40, marking a decrease of 5.93.
• For Enterprise Value (Cr.), as of Mar 25, the value is 105.54. It has decreased from 129.83 (Mar 24) to 105.54, marking a decrease of 24.29.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.14. This value exceeds the healthy maximum of 3. It has decreased from 294.73 (Mar 24) to 9.14, marking a decrease of 285.59.
• For EV / EBITDA (X), as of Mar 25, the value is -5.89. This value is below the healthy minimum of 5. It has increased from -37.59 (Mar 24) to -5.89, marking an increase of 31.70.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.06. This value exceeds the healthy maximum of 3. It has decreased from 243.81 (Mar 24) to 7.06, marking a decrease of 236.75.
• For Price / BV (X), as of Mar 25, the value is -2.04. This value is below the healthy minimum of 1. It has increased from -9.17 (Mar 24) to -2.04, marking an increase of 7.13.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.06. This value exceeds the healthy maximum of 3. It has decreased from 244.37 (Mar 24) to 7.06, marking a decrease of 237.31.
• For EarningsYield, as of Mar 25, the value is -0.38. This value is below the healthy minimum of 5. It has decreased from -0.06 (Mar 24) to -0.38, marking a decrease of 0.32.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness